Jeremy Graff
Chief Tech/Sci/R&D Officer at IMV INC.
Net worth: 5 413 $ as of 2024-05-30
Network origin in Jeremy Graff first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
23
| Public Company | Biotechnology | 23 |
14
| Public Company | Biotechnology | 14 |
Biothera Pharmaceutical, Inc.
 Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN.
7
| Subsidiary | Medical/Nursing Services | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jeremy Graff via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Chairman | |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal General Counsel | |
Immusoft Corp.
 Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Medical/Nursing Services | Director/Board Member | |
410 Medical, Inc.
 410 Medical, Inc. Medical SpecialtiesHealth Technology 410 Medical, Inc. operates as a medical device company. It develops LifeFlow for fluid resuscitation to help patients with life-threatening illnesses such as sepsis. The company was founded by Mark Donald Piehl and Luke Miller Roush in 2013 and is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Brandeis University | College/University | Undergraduate Degree | |
| Dallas Baptist University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member | |
| Yale University | College/University | Graduate Degree | |
| University of Maryland | College/University | Doctorate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Tunnell Consulting, Inc.
 Tunnell Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Tunnell Consulting, Inc. provides technical, organizational and operational consulting services. It provides life sciences technical services, process and organizational excellence services, strategy and supply chain management services. The firm serves in the area of pharmaceutical, government and biotechnology departments. The company was founded in 1962 and is headquartered in King of Prussia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
| University College London | College/University | Graduate Degree | |
| Université Laval | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
| US Department of the Navy (District of Columbia) | Sovereign | Corporate Officer/Principal | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Pharmaceuticals: Major | Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| SKYE BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
Benchsci Analytics, Inc.
 Benchsci Analytics, Inc. Packaged SoftwareTechnology Services Benchsci Analytics, Inc. develops and operates an online platform that extracts usage evidence from scientific papers and organizes it around antibodies. Its platform allows scientists to search millions of papers to find antibody usage data. The company was founded by Liran Belenzon, David Qixiang Chen, Thomas KH Leung, and Elvis Wiandas and is headquartered in Toronto, Canada. | Packaged Software | Director/Board Member | |
| RELAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
BIOS Capital Management LP
 BIOS Capital Management LP Investment ManagersFinance BIOS Capital Management LP (BIOS Partners) is a venture capital firm founded in 2014 by Stella Robertson, Aaron Fletcher and Leslie Kreis. The firm is headquartered in Fort Worth, Texas. | Investment Managers | Private Equity Investor | |
| AZITRAPAR | Pharmaceuticals: Major | Founder | |
BIOS Equity Partners LP
 BIOS Equity Partners LP Investment ManagersFinance Part of BIOS Capital Management LP, BIOS Equity Partners LP functions as a private equity firm. The company is based in Texas. The American company was founded by Leslie W. Kreis. | Investment Managers | Corporate Officer/Principal | |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Noxsudor Therapeutics Ltd.
 Noxsudor Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Noxsudor Therapeutics Ltd. manufactures capsules that control sweating. | Pharmaceuticals: Major | Director/Board Member | |
Ventus Therapeutics, Inc.
 Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Ventus Therapeutics U.S., Inc.
 Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Medical Distributors | Director/Board Member | |
Ryse Asset Management LLP
 Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management LLP (RYSE) is a venture capital firm founded in 2010 by Atique Mirza. The firm is headquartered in London, the United Kingdom. | Investment Managers | Chairman | |
| MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
OS Acquisition Corp.
 OS Acquisition Corp. Financial ConglomeratesFinance OS Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 13, 2021 and is headquartered in Park Ridge, IL. | Financial Conglomerates | Director/Board Member | |
| ETERNA THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
SIRPant Immunotherapeutics, Inc.
 SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki. | Biotechnology | Director/Board Member | |
| Secret Saviours Ltd. | Director/Board Member | ||
Valeas Capital Partners Management LP
 Valeas Capital Partners Management LP Investment ManagersFinance Valeas Capital Partners Management LP (Valeas Capital Partners) is a private equity firm founded in 2021 by Rob O'Connor Little and Edward A. Woiteshek. The firm headquartered in San Francisco, California. | Investment Managers | Private Equity Investor |
Statistics
International
| United States | 36 |
| United Kingdom | 8 |
| Canada | 6 |
| Germany | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Finance | 7 |
| Health Services | 2 |
Operational
| Director/Board Member | 156 |
| Corporate Officer/Principal | 88 |
| Independent Dir/Board Member | 44 |
| Director of Finance/CFO | 36 |
| Undergraduate Degree | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Luba Greenwood | 32 |
| Julia Gregory | 22 |
| Alan Roemer | 21 |
| Pierre Labbé | 19 |
| Walter Ogier | 18 |
| Shermaine Tilley | 17 |
| James Hall | 16 |
| Andrew LaFrence | 16 |
| Barry A. Labinger | 12 |
| Markus Warmuth | 11 |
| Tracy Sherren | 11 |
| Travis Whitfill | 10 |
| Peter Brandt | 10 |
| William Ho | 10 |
- Stock Market
- Insiders
- Jeremy Graff
- Company connections
